Trials / Completed
CompletedNCT03158077
Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection
Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection: Observational Retrospective Study at 48 Weeks - KIRAL Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 467 (actual)
- Sponsor
- Fundacion SEIMC-GESIDA · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective observational study, multicentric with Spanish hospitals, in which a switching or change strategy with RAL and ABC / 3TC guidelines was used, in the48 weeks before the start of the study, in order to determine parameters of Effectiveness and security.
Detailed description
The study consists of a 4-weeks data recording period, during which the follow-up information recorded by physicians in electronic or paper medical history will be analyzed from patients who opted for a change to that study pattern (RAL and ABC / 3TC).
Conditions
Timeline
- Start date
- 2016-11-15
- Primary completion
- 2017-04-20
- Completion
- 2017-04-20
- First posted
- 2017-05-17
- Last updated
- 2017-05-17
Locations
14 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03158077. Inclusion in this directory is not an endorsement.